Predicting Relapse in Patients With Triple Negative Breast Cancer (TNBC) Using a Deep-Learning Approach

by Guangyuan Yu, Guangyuan Yu, Xuefei Li, Ting-Fang He, Tina Gruosso, Tina Gruosso, Dongmei Zuo, Margarita Souleimanova, Valentina Muñoz Ramos, Atilla Omeroglu, Sarkis Meterissian, Sarkis Meterissian, Marie-Christine Guiot, Marie-Christine Guiot, Li Yang, Yuan Yuan, Morag Park, Morag Park, Morag Park, Peter P. Lee, Herbert Levine, Herbert Levine
Published 2020-09-01

Tailoring Immunotherapy Treatment of Synchronous Renal Cell Carcinoma (RCC) and Triple-Negative Breast Cancer (TNBC)

by Iris Y. Sheng, Megan Kruse, Kathryn M. Leininger, Moshe C. Ornstein
Published 2019-01-01

Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51

by Jung Ok Lee, Min Ju Kang, Won Seok Byun, Shin Ae Kim, Il Hyeok Seo, Jeong Ah. Han, Ji Wook Moon, Ji Hae Kim, Su Jin Kim, Eun Jung Lee, Serk In Park, Sun Hwa Park, Hyeon Soo Kim
Published 2019-10-01

Upregulation of endogenous TRAIL-elicited apoptosis is essential for metformin-mediated antitumor activity against TNBC and NSCLC

by Shuang Liu, Erik V. Polsdofer, Lukun Zhou, Sanbao Ruan, Hui Lyu, Defu Hou, Hao Liu, Ann D. Thor, Zhimin He, Bolin Liu
Published 2021-06-01

Ginsenoside panaxatriol reverses TNBC paclitaxel resistance by inhibiting the IRAK1/NF-κB and ERK pathways

by Panpan Wang, Dan Song, Danhong Wan, Lingyu Li, Wenhui Mei, Xiaoyun Li, Li Han, Xiaofeng Zhu, Li Yang, Yu Cai, Ronghua Zhang
Published 2020-06-01

Nomograms for Predicting the Prognostic Value of Pre-Therapeutic CA15-3 and CEA Serum Levels in TNBC Patients.

by Danian Dai, Bo Chen, Hailin Tang, Bin Wang, Zhiping Zhao, Xiaoming Xie, Weidong Wei
Published 2016-01-01

Identification of SNPs within the CYP2A6 enzyme of TNBC cell lines and the resulting change in activity

by Dingle, Laura Margaret Kirkpatrick
Published 2017

Identification of SNPs within the CYP2A6 enzyme of TNBC cell lines and the resulting change in activity

by Dingle, Laura Margaret Kirkpatrick
Published 2017

Identification of SNPs within the CYP2A6 enzyme of TNBC cell lines and the resulting change in activity

by Dingle, Laura Margaret Kirkpatrick
Published 2017

The pro- and anti-tumor roles of mesenchymal stem cells toward BRCA1-IRIS-overexpressing TNBC cells

by Daniel Ryan, Bibbin T. Paul, Jim Koziol, Wael M. ElShamy
Published 2019-04-01

Efficacy and safety of neoadjuvant therapy for Triple-Negative Breast Cancer (TNBC): a Bayesian network meta-analysis

by Y. Yu, J. Zhang, Y. Lin, S. Kang, X. Lv, C. Song
Published 2021-04-01

The Assessment of Response to Adjuvant Chemotherapy with CMF in Triple Negative Breast Cancer

by Seyyed Asadolah Mousavi, Efat Mashhadi, Masud Iravani, Ardeshir Ghavamzade
Published 2013-03-01

The Assessment of Response to Adjuvant Chemotherapy with CMF in Triple Negative Breast Cancer

by Seyyed AsadoLah Mousavi, Efat Mashhadi, Masud Iravani, Ardeshir Ghavamzade
Published 2013-01-01

Cyclin B2 (CCNB2) Stimulates the Proliferation of Triple-Negative Breast Cancer (TNBC) Cells In Vitro and In Vivo

by Shuai Wu, Rui Su, Hongyan Jia
Published 2021-01-01

The autoregulatory serglycin/CD44 axis drives stemness‐like phenotypes in TNBC in a β‐catenin‐dependent manner

by Li Cao, Fei‐Fei Luo, Hong‐Bin Huang, Tie‐Jun Huang, Hao Hu, Li‐Sheng Zheng, Jing Wang, Li‐Xia Peng, Chao‐Nan Qian, Bi‐Jun Huang
Published 2021-02-01

DAXX, as a Tumor Suppressor, Impacts DNA Damage Repair and Sensitizes BRCA-Proficient TNBC Cells to PARP Inhibitors

by Yaqin Shi, Juan Jin, Xin Wang, Wenfei Ji, Xiaoxiang Guan
Published 2019-06-01

EGCG-Derivative G28 Shows High Efficacy Inhibiting the Mammosphere-Forming Capacity of Sensitive and Resistant TNBC Models

by Ariadna Giró-Perafita, Marc Rabionet, Marta Planas, Lidia Feliu, Joaquim Ciurana, Santiago Ruiz-Martínez, Teresa Puig
Published 2019-03-01

The Novel Mnk1/2 Degrader and Apoptosis Inducer VNLG-152 Potently Inhibits TNBC Tumor Growth and Metastasis

by Senthilmurugan Ramalingam, Vidya P. Ramamurthy, Lalji K. Gediya, Francis N. Murigi, Puranik Purushottamachar, Weiliang Huang, Eun Yong Choi, Yuji Zhang, Tadas S Vasaitis, Maureen A. Kane, Rena G. Lapidus, Vincent C. O. Njar
Published 2019-03-01

Molecular subtyping and functional validation of TTK, TPX2, UBE2C, and LRP8 in sensitivity of TNBC to paclitaxel

by Ramesh Elango, Radhakrishnan Vishnubalaji, Hibah Shaath, Nehad M. Alajez
Published 2021-03-01

Unexpected PD‐L1 immune evasion mechanism in TNBC, ovarian, and other solid tumors by DR5 agonist antibodies

by Tanmoy Mondal, Gururaj N Shivange, Rachisan GT Tihagam, Evan Lyerly, Michael Battista, Divpriya Talwar, Roxanna Mosavian, Karol Urbanek, Narmeen S Rashid, J Chuck Harrell, Paula D Bos, Edward B Stelow, M Sharon Stack, Sanchita Bhatnagar, Jogender Tushir‐Singh
Published 2021-03-01